Abstract
Introduction:
Heat therapy (HT), particularly in the form of whole-body sauna bathing, has emerged as a promising intervention for the management of cardiovascular disease (CVD). Passive HT can induce both local and systemic physiological responses, primarily through repeated thermal stress consisting of short-term passive exposure to high temperatures. Such responses closely parallel the physiological adaptations observed during aerobic exercise. Peripheral arterial disease (PAD) poses significant health challenges, impacting millions of individuals worldwide. Supervised exercise is considered a cornerstone therapy for PAD, yet many patients face significant health-related barriers that complicate its broad implementation.
Methods:
We conducted a comprehensive review of the literature to explore the therapeutic implications of various HT practices beyond sauna. The review aimed to evaluate the potential use of these practices as adjunctive management strategies for cardiovascular diseases, particularly in patients with PAD.
Results:
Recent studies have demonstrated the potential role of HT in alleviating PAD symptoms, improving functional capacity, and reducing cardiovascular and limb events. HT practices might be beneficial as adjunctive management strategies, in addition to or as alternatives to exercise, for management of cardiovascular diseases.
Discussion:
This review highlights the potential benefits, underlying mechanisms of action, challenges, and safety considerations associated with HT. We emphasize the importance of exploring HT as a viable option for patients with cardiovascular conditions, particularly those with PAD, who face barriers to traditional exercise regimens.
1 Introduction
Peripheral arterial disease (PAD) is a major circulatory problem characterized by diminished arterial blood flow that predominantly impacts the lower extremities. It carries significant morbidity, mortality, and quality of life impairment. Principally a manifestation of atherosclerosis, the prevalence of PAD increases with age (, ). PAD-related functional impairment is associated with increased rates of hospitalization, interventions to attempt limb salvage, and functional disability (, ). Current estimates suggest that PAD affects over 230 million individuals worldwide and more than 29% of high-risk individuals in the United States (US), which include individuals over 70 years or with a history of smoking or diabetes mellitus (). Significantly, the global incidence of PAD has risen by approximately 45% from 2000 to 2015, with greater increases in low- and middle-income countries, although prevalence remains overall higher in high-income countries (). PAD is linked to most forms of cardiovascular disease (, ) such as, dyslipidemia, hypertension, coronary artery disease, and cerebrovascular disease. Lower extremity PAD presents in a spectrum of clinical manifestations, including intermittent claudication, rest pain, tissue loss, and occasionally atypical symptoms linked to ischemia (). Therefore, medical interventions and risk factor modifications constitute essential elements of evidence-based PAD care. Such strategies are crucial not only for improving cardiovascular morbidity and mortality, but for enhancing limb-related outcomes as well (, ).
The American Heart Association/American College of Cardiology (AHA/ACC) guidelines recommend that patients with PAD receive a comprehensive program of guideline-directed medical therapy based on four pillars: statin therapy to reduce hyperlipidemia, antiplatelet therapy, smoking cessation therapy/counseling, and supervised exercise therapy programs (SEPs) (–). Guideline-directed medical therapy should also be customized to manage co-morbidities such as diabetes mellitus or hypertension. Patients with lifestyle-limiting claudication despite optimal medical therapy and those with chronic limb-threatening ischemia should be considered for surgical intervention and attempted revascularization. The aim of guideline-directed medical therapy and surgery is to improve patient symptoms, preserve limb function, and enhance quality of life. It is also recommended for all stages of PAD, including post-revascularization (–).
While there is strong adherence to pivotal pharmacological therapies such as antiplatelet and statin medications, adherence to non-pharmacological interventions, including smoking cessation and SEP, remains significantly low (, –). Moreover, such non-pharmacological interventions offered to PAD patients exhibit a highly variable degree of compliance, especially for SEPs and other home exercise programs (). Consequently, while adherence can be as high as 90% in certain regions of Europe, rates are drastically lower in the US, often ranging from 0 to 10% (). Noteworthy, there is a strong evidence base to support a central role of structured exercise programs (), however many PAD patients, particularly those with chronic limb-threatening ischemia, may be unable or unwilling to engage in SEPs or home exercise programs. Because of this, there is an ongoing need for a more viable alternative or adjunctive therapy to alleviate symptoms, improve function, and reduce cardiovascular and limb events especially in individuals who are unable to regularly exercise.
In recent decades, heat therapy (HT) has emerged not only as a tool for relaxation, but also as a novel treatment option for various health concerns. Traditionally, repeated HT can be obtained in the form of whole-body, also known as “sauna bathing,” which has been associated with numerous health benefits (–). Similarly, regional or localized body thermotherapies have also demonstrated substantial health benefits (–). The therapeutic benefits of HT have been consistently documented in diseases that significantly impact lifespan. For example, neurologic conditions, including stroke, dementia, and psychotic disorders have benefited from HT (–). Similarly, patients with lung conditions such as asthma, chronic obstructive pulmonary disease, and pulmonary hypertension have observed functional improvement, further contributing to lifespan extension (, –).
In terms of cardiovascular health, numerous preclinical and clinical studies suggest that regular or frequent exposure to passive HT reduces the risk of cardiovascular diseases. For example, studies have demonstrated that HT can improve conditions such as hypertension, venous thromboembolism, heart failure, and overall cardiovascular disease (CVD) mortality (, , ). Similarly, other forms of whole-body HT, such as Waon therapy, have gained popularity for their role in peripheral vascular disease (). Practices that involve localized body thermotherapy have also shown a positive impact on cardiovascular health (–). HT replicates the physiological benefits of aerobic exercise, suggesting its potential utility in the management of CVD and PAD (, ), particularly for patients who are unable to engage in physical activity. An important question that remains is whether these HT practices could be strategically implemented to enhance the management of PAD.
This review focuses on the preclinical, epidemiological, and interventional evidence indicating implementation of various HT practices and their potential roles in the management of PAD and CVD. Furthermore, our comprehensive review explores the mechanistic pathways that could potentially influence the effectiveness of passive HT on cardiovascular health outcomes. Given the plethora of HT practices that have been tested and are commercially available, we specifically concentrated on the clinical evidence associated with sauna bathing and the areas currently undergoing active research.
2 Whole-body heat therapy: Finnish-style sauna and Waon therapy
Most studies on HT have focused on the use of whole-body Finnish-style sauna bathing. Although HT practices can vary by heat source, temperature, relative humidity, and usage duration (Table 1), the traditional Finnish-style sauna bathing is usually the model of reference. Sauna bathing is a form of passive HT characterized by dry air and the exposure to high temperature for a brief period. The recommended temperature ranges from 80°C to 100°C, while the relative humidity ranges from 10%–20% (). The heating source is composed of hot rocks (including wood-fired, gas and electric models), and the sauna is usually made of wood with wooden benches well above the floor upon which bathers sit (). Typical sauna sessions consist of short stays in the sauna room ranging between 5 and 20 min. Sauna sessions can be interspersed with cooling-off periods (swim, shower, or room temperature acclimation). A typical Finnish-style sauna bath occurs at least once per week, with the average habitual frequency being 2–4 times per week (, , , ).
Table 1
| Heat therapies | Whole-body heat therapy | Localized heat therapy | Combined | |||
|---|---|---|---|---|---|---|
| Finnish-style sauna bathing | Waon therapy | Hot water immersion | Pulsed shortwave diathermy (PSD) | Heated water | Far infrared (FIR) | |
| Description | Dry air in a wood paneled room | Infrared heat in a closed chamber | Head out water immersion in a hot tub | Deep heat within body tissues | Water-circulating or spa bathing | Lamps or heating elements that emit FIR |
| Heat source | Sauna heater:
| Infrared heat Warmed blankets (keep temp) | Heated water Blankets and water bottles (keep temp) | Electromagnetic radiation | Heat trousers Hot water immersion | Thermal radiation
|
| Temp °C (°F) | 80–100 (158–212) | 60 (140) | 40 (104) | Raises tissue temperature by 3.9 (39) | 48 (118) | 45–68 (113–150) |
| Duration | 5–20 min | 15 min (inside) 30 min (outside) | 30 min (inside) 90 min (total) | Variable | Variable | Variable |
Heat therapies (HT) overview.
Waon therapy, another prevalent form of dry sauna practice, involves using an evenly heated chamber to envelop the entire body in soothing warmth (, ). In Japanese, the term “Waon” translates to “comfortable warmth that refreshes the mind and body” (). This whole-body HT, as outlined in Table 1, consists of a two-step process: first, a 15-minute session of infrared heat exposure in a sauna heated to approximately 60°C, raising the core body temperature by about 1.0°C–1.2°C; second, participants lie supine outside the sauna while covered in warm blankets to maintain this temperature for an additional 30 min (, ). Widely available, this popular sauna therapy improves hemodynamics and cardiac function without severe adverse effects (). Other less popular whole-body HTs include steam rooms (100% humidity) and whole-body hyperthermia, a method which uses radiation, convection, or conduction to produce heat ().
Another effective form of whole-body HT can be achieved through repeated hot water immersion, also known as hot “head-out” water immersion (–). In this method, subjects are immersed up to the shoulders or sternum (typically with arms out) in a hot tub maintained at 40°C for approximately 30 min, increasing body temperature by 0.6–0.8°C (Table 1). Following this initial phase, subjects may sit on a bench with water reaching waist level to maintain the elevated temperature for an additional 30–60 min, with a maximum total exposure of 90 min (). This approach has shown to be the most effective passive hyperthermia method for inducing classical markers of heat acclimation and increasing heat-related proteins (). Alternatively, subjects can lie on a lounge chair, wrapped in warm blankets with hot water bottles placed on the abdomen and thighs for at least 30 min ().
3 Localized and combined heat therapy
Local/regional-body thermotherapy uses direct contact with a heated liquid (such as water or wax), hot blankets or suits, heating coils, or specialized lamps that emit infrared-A radiation to target a specific region of the body ().
Despite only targeting a specific area, selective immersion of the legs in hot water can still impact circulatory parameters, including cardiac output, stroke volume, and heart rate (). To illustrate, localized HT applied with customized water-circulating trousers can increase popliteal artery blood flow, lower blood pressure and reduce vasoconstriction (). Using this modality, specialized tube-lined trousers that are filled with heated water at 48°C is applied for 90 min, 3 times per week (Table 1). Compared to a sham group, such intervention improved the perceived physical function in patients with PAD (). Similarly, the use of pulsed shortwave diathermy, another form of repeated exposure to heat stress that promotes deep tissue heating, demonstrated beneficial heat-induced mitochondrial adaptations in human skeletal muscle (, ).
Infrared heaters emit thermal radiation, which heats the body directly. They operate at lower temperatures than traditional saunas, at 45°C–65.5°C. Infrared heaters emit either near or far wavelengths (typically from 0.75 to 1000 μm), which permit their use as a “combined” heat source (Table 1) for either whole or localized-body therapies. This modality uses incandescent bulbs to produce thermal radiation of varying wavelengths, ranging from near-infrared wavelengths (0.75–1.5 μm) to middle-infrared (1.5–5.6 μm) wavelengths. Far infrared (FIR) heaters use ceramic or metallic heating elements that emit energy in the far-infrared range (5.6–1000 μm), typically at wavelengths of approximately 10 μm (). A study conducted in Taiwan evaluated the application of FIR therapy in the upper extremities and demonstrated significantly improved hemodialysis access flow and unassisted patency ().
4 Physiologic responses to heat stress and proposed mechanisms of action
When the body is exposed to high temperatures, it responds with a rapid physiological reaction primarily impacting the skin and cardiovascular systems. Initially, the skin temperature rises to approximately 40°C, followed by a gradual increase in core body temperature (, , ). This thermal stress (Figure 1) induces an increase in cardiac output by up to 60%–70%, with elevated heart rate and a stable stroke volume (, ). Simultaneously, the body's circulatory system redistributes approximately 50%–70% of its blood flow from the core to the skin, facilitating sweating and driving fluid losses (, , , ). Repeated sauna sessions help the body adapt to heat, improving its ability to handle subsequent exposures. This is attributed to a biological phenomenon known as hormesis, wherein exposure to a mild stressor elicits a compensatory defense response (, ) (Figure 1). This response activates a variety of protective mechanisms that repair cellular damage and provide protection against more severe stressors (, , , ).
Figure 1
The physiological responses to sauna bathing bear a striking resemblance to those experienced during moderate to vigorous aerobic exercise (). For example, passive HT through whole-body water immersion promotes vasodilation and concurrently impacts arterial stiffness, wall thickness, and blood pressure (, ). Although both whole-body and local heating strategies notably impact blood flow, it is important to highlight that only local heating significantly enhances muscle blood flow, whereas whole-body heating predominantly increases skin blood flow ().
On a molecular level, heat stress activates a series of mechanisms that stimulate endogenous antioxidant, repair, and degradation processes. One such mechanism is the increased expression of heat shock proteins (HSPs), a highly conserved family of proteins present in all cells (). Passive HT has been demonstrated to significantly boost HSP expression in circulating leukocytes (), subcutaneous adipose tissue () and notably, skeletal muscle tissue in humans (, ). These proteins play a critical role in protecting cells from the harmful effects of heat and other stressors (). HSPs also play vital roles under normal conditions, contributing to immune function, cell signaling, cell-cycle regulation, and proteostasis. By repairing damaged proteins, HSPs prevent protein disorder and aggregation, a common feature in age-related diseases (, –64). Additionally, HSPs have been found to positively influence cardiovascular function by modulating nitric oxide pathways, and mitigating chronic oxidative stress and vascular inflammation ().
Another key molecular player in the heat stress response is nuclear factor erythroid 2–related factor 2 (Nrf2), a regulator of the cellular antioxidant response. Upon activation by heat stress, Nrf2 translocates from the cytoplasm to the nucleus, orchestrating the regulation of a vast network of genes involved in cytoprotective, antioxidant, and anti-inflammatory functions (, , 65). Specifically, heat-activated Nrf2 has been shown to suppress pro-inflammatory molecules involved in CVD, such as E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1, through the upregulation of HSP heme oxygenase-1 (, ). In summary, while heat exposure induces a robust cellular stress response, causing upregulation of protective proteins and pathways, this does not necessarily result in cellular damage. Rather, the repetitive stress responses induced by HT may offer protective benefits, particularly in the context of cardiovascular disease ().
In conditions such as congestive heart failure, coronary artery disease, and PAD, sauna bathing can ameliorate myocardial perfusion abnormalities (, ). As seen in Figure 1, nitric oxide, produced by endothelial nitric oxide synthase (eNOS), is a main playmaker during thermal stress. Patients with CVD often exhibit reduced nitric oxide bioavailability (66). Repeated heat exposure increases cardiac output and the shear stress of the vessel wall, ultimately leading to enhanced eNOS expression in the arterial endothelium (67, 68). This results in eNOS-dependent mobilization of endothelial progenitor cells and enhanced angiogenesis (, , , 69, 70). Furthermore, FIR radiation has been shown to inhibit the tumor necrosis factor -α-mediated expression of the adhesion molecules E-selectin, vascular cell adhesion molecule-1, intercellular adhesion molecule-1, as well as the downregulation of chemo-attractants monocyte chemo-attractant protein-1 (MCP-1) and interleukin-8 (IL-8), all of which enhance endothelial function ().
5 Potential benefits of sauna for management of CVD and PAD
A growing body of evidence suggests that beyond its use for pleasure and relaxation, sauna bathing transcends these conventional roles, providing potential health benefits (Figure 1). The potential benefits of passive HT, particularly sauna bathing, in the management of CVD and PAD are supported by clinical evidence and are becoming increasingly recognized (, , , , ). Heat exposure elicits protective responses that promote cardiovascular health, mirroring the beneficial adaptations associated with exercise training (). In a randomized controlled trial (RCT) (), the combination of sauna exposure and exercise was demonstrated to synergistically enhance cardiorespiratory fitness, resulting in greater reductions in systolic and diastolic blood pressure as well as total cholesterol levels, compared to either exercise or sauna alone (, 71). For sedentary populations, such as individuals with disabilities, wheelchair users, those on non-weightbearing status or the elderly, performing regular exercise with its associated anti-inflammatory benefits may not be feasible. Therefore, manipulating body temperature could serve as an alternative to potentially mitigate cardiovascular events. In this context, sauna bathing emerges as a potential therapeutic option that might be effective and carries low risk.
In the context of PAD, primarily associative data from studies utilizing Waon therapy have shown significant decreases in pain scores and increases in 6-minute walk distance, ankle-brachial index, and blood flow as assessed by laser doppler perfusion imaging (). However, a RCT with a larger and more diverse group of PAD patients is crucial to confirm the efficacy of Waon therapy. Moreover, early study findings demonstrated that regular sauna use may help induce new collateral vessel formation as visualized on angiography—suggesting that such therapies may promote angiogenesis and formation of new collaterals (). In some cases, ischemic ulcers have been reported to have markedly improved healing without the need for invasive therapy (, , , , , 69, 70).
Operatively, the success of peripheral revascularization, whether open or endovascular, largely depends on adequate outflow, which is an independent risk factor for patency. Individuals with PAD frequently suffer from both macro- and microvascular disease (, ). In this regard, repeated HT may improve outflow microvasculature which could improve healing and improved outflow following revascularization (Figure 1). Patients with end-stage PAD without revascularization options may benefit even more from this therapy, since they have limited revascularization options for limb salvage. In Japan, patients frequently continue to undergo Waon therapy in the outpatient clinic at least twice weekly after peripheral revascularization (). However, RCT with systematic follow-up studies are essential to draw definitive conclusions regarding the long-term benefits and outcomes of this therapy.
Most patients with CVD also suffer from end-stage renal disease, necessitating vascular access, which is crucial for delivering essential dialysis treatment. Unfortunately, arteriovenous fistulas or grafts can be prone to complications, such as failure to mature or thrombosis, making them a significant cause of morbidity leading to frequent hospitalizations and interventions in the US (72). Furthermore, there are no approved interventions or guidelines for the prevention of arteriovenous access failure, other than ultrasound routine follow up. In Taiwan, a RCT showed that FIR therapy helps prevent arteriovenous access failure and has gained widespread acceptance as a therapeutic approach (73). Hemodialysis centers worldwide are increasingly embracing this innovative treatment option to enhance maturation rates and sustain access patency for improved patient outcomes (, 73). Further research and evaluation of guidelines are necessary to tailor the applicability of this therapy in the US, as well as to identify and address potential complications or limitations to this technique.
6 Safety and tolerability
Although sauna is generally well tolerated and safe, especially in healthy individuals, there are some contraindications to consider. According to a review of cases done by Luurila et al., alcohol consumption combined with sauna use can significantly increase sudden death (74). The researchers also recommended that “natural contraindications,” such as infectious diseases, acute chest pain, unstable angina pectoris, decompensated heart failure, and tight aortic stenosis should be considered as contraindications. Although these suggestions are logical and anticipate precautions to prevent complications, further evidence is necessary to definitively establish a correlation. Prospective studies are required to elucidate the correlation and risk associated with sauna use in such populations.
Importantly, antihypertensive medication use immediately before bathing is also not advisable as it may predispose the individual to orthostatic hypotension (75). Concerns about male fertility have been raised due to scrotal hyperthermia and altered spermatogenesis. A small study indicated decreased sperm count and motility; however, these effects were reversible within 6 months of discontinuing sauna use (76). On another front, some central nervous system birth defects, including anencephaly and spina bifida, have been associated with extreme heat exposure during pregnancy (77). Paradoxically, in Finland, where most women engage in weekly sauna bathing throughout pregnancy, the incidence of anencephaly is the lowest globally (78). Also, observational studies in both Finland and the US have failed to establish links between sauna use and a higher incidence of cardiovascular or neurological malformations, the most prevalent type of birth defect (75). Lastly, severe adverse effects may result from accidents, such as burns from the heater and drowning during a cool-off swim, with alcohol often contributing to these incidents (75).
7 Discussion
In summary, the current body of evidence suggests that passive HT, particularly in the form of sauna bathing, holds promise as a therapeutic intervention for PAD and offers a low-risk and potentially effective option for treatment. The physiological and molecular responses to heat stress mimic those of moderate to vigorous aerobic exercise, potentially alleviating symptoms, improving functional status, and reducing cardiovascular and limb events in PAD patients (Figure 1). However, it is important to note that all HT practices discussed in this review are not currently approved by the US Food and Drug Administration (FDA). The development of HT as potential treatments often relies on preliminary research, highlighting the necessity for further studies to elucidate the mechanisms driving its positive effects. Although our review incorporates a significant number of RCTs over associative studies, it is evident that the scientific rigor of the existing research remains in need of improvement. Moreover, the limited number of high-quality RCTs with large sample sizes and standardized multi-center approaches poses a challenge for conducting a thorough systematic review of the existing literature. Future studies should aim to address the current gaps in the evidence, particularly concerning the long-term effects of heat therapy and its efficacy in diverse patient populations. Finally, it is essential to develop and implement a standard and practical protocol for the application of HT in managing PAD. Establishing consensus on these optimal procedures will optimize its use and potentially enhance patient outcomes.
Statements
Author contributions
SS-D: Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Validation, Writing – original draft, Writing – review & editing. SE-B: Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Project administration, Validation, Writing – original draft, Writing – review & editing. MZ: Funding acquisition, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was supported by NIH/NHLBI R01HL153262 and R01HL150891, and NIH/NIBIB T32EB021955.
Acknowledgments
We would like to extend our sincerely gratitude to Jody Horn, from the Division of Surgical Sciences at Washington University in St. Louis, for her exceptional and thorough editorial review of this manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that can be perceived as a potential conflict of interest.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1.
McDermottMMGuralnikJMTianLFerrucciLLiuKLiaoYet alBaseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease. J Am Coll Cardiol. (2007) 50:974–82. 10.1016/j.jacc.2007.05.030
2.
McDermottMMGuralnikJMTianLLiuKFerrucciLLiaoYet alAssociations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up. The WALCS (walking and leg circulation study). J Am Coll Cardiol. (2009) 53(12):1056–62. 10.1016/j.jacc.2008.09.063
3.
AdayAWMatsushitaK. Epidemiology of peripheral artery disease and polyvascular disease. Circ Res. (2021) 128:1818–32. 10.1161/CIRCRESAHA.121.318535
4.
CampiaUGerhard-HermanMPiazzaGGoldhaberSZ. Peripheral artery disease: past, present, and future. Am J Med. (2019) 132:1133–41. 10.1016/j.amjmed.2019.04.043
5.
HirschATCriquiMHTreat-JacobsonDRegensteinerJGCreagerMAOlinJWet alPeripheral arterial disease detection, awareness, and treatment in primary care. JAMA. (2001) 286:1317–24. 10.1001/jama.286.11.1317
6.
Gerhard-HermanMDGornikHLBarrettCBarshesNRCorriereMADrachmanDEet al2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. (2017) 135:e686–725. 10.1161/cir.0000000000000470
7.
SaxonJTSafleyDMMena-HurtadoCHeyligersJFitridgeRShishehborMet alAdherence to guideline-recommended therapy—including supervised exercise therapy referral—across peripheral artery disease specialty clinics: insights from the international PORTRAIT registry. J Am Heart Assoc. (2020) 9:e012541. 10.1161/JAHA.119.012541
8.
LinENguyenCHThomasSG. Completion and adherence rates to exercise interventions in intermittent claudication: traditional exercise versus alternative exercise—a systematic review. Eur J Prev Cardiol. (2019) 26:1625–33. 10.1177/2047487319846997
9.
LaneRHarwoodAWatsonLLengGC. Exercise for intermittent claudication. Cochrane Database Syst Rev. (2017) 12:CD000990. 10.1002/14651858.CD000990.pub.4
10.
ZierlerREJordanWDLalBKMussaFLeersSFultonJet alThe society for vascular surgery practice guidelines on follow-up after vascular surgery arterial procedures. J Vasc Surg. (2018) 68(1):256–84. 10.1016/j.jvs.2018.04.018s
11.
NorgrenLHiattWRDormandyJANehlerMRHarrisKAFowkesFGR. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. (2007) 45(Suppl S):S5–67. 10.1016/j.jvs.2006.12.037
12.
ConteMSBradburyAWKolhPWhiteJVDickFFitridgeRet alGlobal vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. (2019) 69:3S–1255.e40. 10.1016/j.jvs.2019.02.016
13.
EserPGonzalez-JaramilloNWeberSFritscheJFemianoRWernerCet alObjectively measured adherence to physical activity among patients with coronary artery disease: comparison of the 2010 and 2020 world health organization guidelines and daily steps. Front Cardiovasc Med. (2022) 9:951042. 10.3389/fcvm.2022.951042
14.
ChengYMouLLiZ. Trends in adherence to recommended physical activity and its association with cardiovascular risk factors in US adults with cardiovascular disease: a cross-sectional study. BMC Cardiovasc Disord. (2022) 22:413. 10.1186/s12872-022-02854-9
15.
ElgersmaKMBrownRJLSalisburyDLStigenLGildeaLLarsonKet alAdherence and exercise mode in supervised exercise therapy for peripheral artery disease. J Vasc Nurs. (2020) 38:108–17. 10.1016/j.jvn.2020.07.002
16.
HirschATHaskalZJHertzerNRBakalCWCreagerMAHalperinJLet alACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American association for vascular surgery/society for vascular surgery, society for cardiovascular angiography and interventions, society for vascular medicine and biology, society of interventional radiology, and the ACC/AHA task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): endorsed by the American association of cardiovascular and pulmonary rehabilitation; national heart, lung, and blood institute; society for vascular nursing; TransAtlantic inter-society consensus; and vascular disease foundation. Circulation. (2006) 113:e463–654. 10.1161/CIRCULATIONAHA.106.174526
17.
PatrickRPJohnsonTL. Sauna use as a lifestyle practice to extend healthspan. Exp Gerontol. (2021) 154:111509. 10.1016/j.exger.2021.111509
18.
SobajimaMNozawaTIhoriHShidaTOhoriTSuzukiTet alRepeated sauna therapy improves myocardial perfusion in patients with chronically occluded coronary artery-related ischemia. Int J Cardiol. (2013) 167:237–43. 10.1016/j.ijcard.2011.12.064
19.
LaukkanenTKhanHZaccardiFLaukkanenJA. Association between sauna bathing and fatal cardiovascular and all-cause mortality events. JAMA Intern Med. (2015) 175:542–8. 10.1001/jamainternmed.2014.8187
20.
KällströmMSoveriIOldgrenJLaukkanenJIchikiTTeiCet alEffects of sauna bath on heart failure: a systematic review and meta-analysis. Clin Cardiol. (2018) 41:1491–501. 10.1002/clc.23077
21.
LeeEKolunsarkaIKostensaloJAhtiainenJPHaapalaEAWilleitPet alEffects of regular sauna bathing in conjunction with exercise on cardiovascular function: a multi-arm, randomized controlled trial. Am J Physiol Regul Integr Comp Physiol. (2022) 323:R289–99. 10.1152/ajpregu.00076.2022
22.
SobajimaMNozawaTShidaTOhoriTSuzukiTMatsukiAet alRepeated sauna therapy attenuates ventricular remodeling after myocardial infarction in rats by increasing coronary vascularity of noninfarcted myocardium. Am J Physiol Heart Circ Physiol. (2011) 301:H548–54. 10.1152/ajpheart.00103.2011
23.
AkermanAPThomasKNVan RijAMBodyEDAlfadhelMCotterJD. Heat therapy vs. supervised exercise therapy for peripheral arterial disease: a 12-wk randomized, controlled trial. Am J Physiol Heart Circ Physiol. (2019) 316:1495–506. 10.1152/ajpheart.00151.2019
24.
MonroeJCLinCPerkinsSMHanYWongBJMotaganahalliRLet alLeg heat therapy improves perceived physical function but does not enhance walking capacity or vascular function in patients with peripheral artery disease. J Appl Physiol. (2020) 129:1279–89. 10.1152/japplphysiol.00277.2020
25.
ChenCFChenFATanACLeeTLChanCHLinCC. Far-infrared therapy improves ankle brachial index in hemodialysis patients with peripheral artery disease. Heart Vessels. (2019) 34:435–41. 10.1007/s00380-018-1259-5
26.
LinCCYangWC. Prognostic factors influencing the patency of hemodialysis vascular access: literature review and novel therapeutic modality by far infrared therapy. J Chin Med Assoc. (2009) 72:109–16. 10.1016/S1726-4901(09)70035-8
27.
KunutsorSKKhanHZaccardiFLaukkanenTWilleitPLaukkanenJA. Sauna bathing reduces the risk of stroke in Finnish men and women: a prospective cohort study. Neurology. (2018) 90:e1937–44. 10.1212/WNL.0000000000005606
28.
LaukkanenTLaukkanenJAKunutsorSK. Sauna bathing and risk of psychotic disorders: a prospective cohort study. Med Princ Pract. (2019) 27:562–9. 10.1159/000493392
29.
LaukkanenTKunutsorSKauhanenJLaukkanenJA. Sauna bathing is inversely associated with dementia and Alzheimer’s disease in middle-aged Finnish men. Age Ageing. (2017) 46:245–9. 10.1093/ageing/afw212
30.
KunutsorSKLaukkanenTLaukkanenJA. Sauna bathing reduces the risk of respiratory diseases: a long-term prospective cohort. Eur J Epidemiol. (2017) 32:1107–11. 10.1007/s10654-017-0311-6
31.
UmeharaMYamaguchiAItakuraSSuenagaMSakakiYNakashikiKet alRepeated waon therapy improves pulmonary hypertension during exercise in patients with severe chronic obstructive pulmonary disease. J Cardiol. (2008) 51:106–13. 10.1016/j.jjcc.2008.01.004
32.
KunutsorSKLaukkanenJA. Does the combination of finnish sauna bathing and other lifestyle factors confer additional health benefits? A review of the evidence. Mayo Clin Proc. (2023) 98:915–26. 10.1016/j.mayocp.2023.01.008
33.
ZaccardiFLaukkanenTWilleitPKunutsorSKKauhanenJLaukkanenJA. Sauna bathing and incident hypertension: a prospective cohort study. Am J Hypertens. (2017) 30:1120–5. 10.1093/ajh/hpx102
34.
KunutsorSKMäkikallioTHKhanHLaukkanenTKauhanenJLaukkanenJA. Sauna bathing reduces the risk of venous thromboembolism. Eur J Epidemiol. (2019) 34:983–6. 10.1007/s10654-019-00544-z
35.
TeiCShinsatoTMiyataMKiharaTHamasakiS. Waon therapy improves peripheral arterial disease. J Am Coll Cardiol. (2007) 50:2169–71. 10.1016/j.jacc.2007.08.025
36.
HannukselaMLEllahhamS. Benefits and risks of sauna bathing. Am J Med. (2001) 110(2):110118–26. 10.1016/s0002-9343(00)00671-9
37.
KauppinenK. Facts and fables about sauna. Ann N Y Acad Sci. (1997) 813:654–62. 10.1111/j.1749-6632.1997.tb51764-x
38.
LaukkanenJALaukkanenTKunutsorSK. Cardiovascular and other health benefits of sauna bathing: a review of the evidence. Mayo Clin Proc. (2018) 93:1111–21. 10.1016/j.mayocp.2018.04.008
39.
MiyataMTeiC. Waon therapy for cardiovascular disease: innovative therapy for the 21st century. Circ J. (2010) 74:617–21. 10.1253/circj.cj.09-0939
40.
TeiCImamuraTKinugawaKInoueTMasuyamaTInoueHet alWaon therapy for managing chronic heart failure—results from a multicenter prospective randomized WAON-CHF study. Circ J. (2016) 80:827–34. 10.1253/circj.CJ-16-0051
41.
MiyataMKiharaTKubozonoTIkedaYShinsatoTIzumiTet alBeneficial effects of waon therapy on patients with chronic heart failure: results of a prospective multicenter study. J Cardiol. (2008) 52:79–85. 10.1016/j.jjc.2008.07.009
42.
WorleyMLReedELKueck PJDirrJKlaesNSchladerZJet alHot head-out water immersion does not acutely alter dynamic cerebral autoregulation or cerebrovascular reactivity to hypercapnia. Temperature. (2021) 8:381–401. 10.1080/23328940.2021.1894067
43.
NaumannJGrebeJKaifelSWeinertTSadaghianiCHuberR. Effects of hyperthermic baths on depression, sleep and heart rate variability in patients with depressive disorder: a randomized clinical pilot trial. BMC Complement Altern Med. (2017) 17:172. 10.1186/s12906-017-1676-5
44.
BaileyTGCableNTMillerGDSprungVSLowDAJonesH. Repeated warm water immersion induces similar cerebrovascular adaptations to 8 weeks of moderate-intensity exercise training in females. Int J Sports Med. (2016) 37:757–65. 10.1055/s-0042-106899
45.
BruntVEEymannTMFranciscoMAHowardMJMinsonCT. Passive heat therapy improves cutaneous microvascular function in sedentary humans via improved nitric oxide-dependent dilation. J Appl Physiol. (2016) 121:716–23. 10.1152/japplphysiol.00424.2016
46.
BruntVEHowardMJFranciscoMAElyBRMinsonCT. Passive heat therapy improves endothelial function, arterial stiffness and blood pressure in sedentary humans. J Physiol. (2016) 594:5329–42. 10.1113/JP272453
47.
SautilletBBourdillonNMilletGPLemaîtreFCozetteMDelanaudSet alHot water immersion: maintaining core body temperature above 38.5°C mitigates muscle fatigue. Scand J Med Sci Sports. (2024) 34:e14503. 10.1111/sms.14503
48.
NeffDKuhlenhoelterAMLinCWongBJMotaganahalliRLRoseguiniBT. Thermotherapy reduces blood pressure and circulating endothelin-1 concentration and enhances leg blood flow in patients with symptomatic peripheral artery disease. Am J Physiol Regul Integr Comp Physiol. (2016) 311:392–400. 10.1152/ajpregu.00147.2016
49.
HafenPSPreeceCNSorensenJRHancockCRHyldahlRD. Repeated exposure to heat stress induces mitochondrial adaptation in human skeletal muscle. J Appl Physiol. (2018) 125:1447–55. 10.1152/japplphysiol.00383.2018
50.
BeeverR. Far-infrared saunas for treatment of cardiovascular risk factors: summary of published evidence. Can Fam Physician. (2009) 55:691–6.
51.
ChenCFYangWCLinCC. An update of the effect of far infrared therapy on arteriovenous access in end-stage renal disease patients. J Vasc Access. (2016) 17:293–8. 10.5301/jva.5000561
52.
KunutsorSKLavieCJLaukkanenJA. Finnish sauna and COVID-19. Infez Med. (2021) 29:160–2.
53.
KauppinenK. Sauna, shower, and ice water immersion. Physiological responses to brief exposures to heat, cool, and cold. Part III. Body temperatures. Arctic Med Res. (1989) 48:75–86.
54.
LaukkanenTKunutsorSKKhanHWilleitPZaccardiFLaukkanenJA. Sauna bathing is associated with reduced cardiovascular mortality and improves risk prediction in men and women: a prospective cohort study. BMC Med. (2018) 16:219. 10.1186/s12916-018-1198
55.
HeinonenILaukkanenJA. Effects of heat and cold on health, with special reference to finish sauna bathing. Am J Physiol Regul Integr Comp Physiol. (2018) 314:629–38. 10.1152/ajpregu.00115.2017
56.
RadakZIshiharaKTekusEVargaCPosaABaloghLet alExercise, oxidants, and antioxidants change the shape of the bell-shaped hormesis curve. Redox Biol. (2017) 12:285–90. 10.1016/j.redox.2017.02.015
57.
HeinonenIMatthew BrothersRKemppainenJKnuutiJKalliokoskiKKCrandallCG. Local heating, but not indirect whole body heating, increases human skeletal muscle blood flow. J Appl Physiol. (2011) 111:818–24. 10.1152/japplphysiol.00269.2011
58.
BruntVEMinsonCT. Heat therapy: mechanistic underpinnings and applications to cardiovascular health. J Appl Physiol. (2021) 130:1684–704. 10.1152/japplphysiol.00141.2020
59.
BruntVEWiedenfeld-NeedhamKComradaLNMinsonCT. Passive heat therapy protects against endothelial cell hypoxia-reoxygenation via effects of elevations in temperature and circulating factors. J Physiol. (2018) 596:4831–45. 10.1113/JP276559
60.
ElyBRClaytonZSMccurdyCEPfeifferJNeedhamKWComradaLNet alHeat therapy improves glucose tolerance and adipose tissue insulin signaling in polycystic ovary syndrome. Am J Physiol Endocrinol Metab. (2019) 317:172–82. 10.1152/ajpendo.00549.2018
61.
Paul HafenXSAbbottKBowdenJLopianoRChad HancockXRHyldahlRD. Daily heat treatment maintains mitochondrial function and attenuates atrophy in human skeletal muscle subjected to immobilization. J Appl Physiol. (2019) 127:47–57. 10.1152/japplphysiol.01098.2018
62.
YamadaPMAmorimFTMoseleyPRobergsRSchneiderSMYamadaP. Effect of heat acclimation on heat shock protein 72 and interleukin-10 in humans. J Appl Physiol. (2007) 103:1196–204. 10.1152/japplphysiol.00242.2007
63.
AmorimFTFonsecaITMachado-MoreiraCAMagalhãesFdC. Insights into the role of heat shock protein 72 to whole-body heat acclimation in humans. Temperature (Austin). (2015) 2:499–505. 10.1080/23328940.2015.1110655
64.
HuCYangJQiZWuHWangBZouFet alHeat shock proteins: biological functions, pathological roles, and therapeutic opportunities. Med Comm. (2022) 3:e161. 10.1002/mco2.161
65.
IhsanMDeldicqueLMolphyJBrittoFCherifARacinaisS. Skeletal muscle signaling following whole-body and localized heat exposure in humans. Front Physiol. (2020) 11:839. 10.3389/fphys.2020.00839
66.
RoyRWilcoxJWebbAJO’GallagherK. Dysfunctional and dysregulated nitric oxide synthases in cardiovascular disease: mechanisms and therapeutic potential. Int J Mol Sci. (2023) 24:15200. 10.3390/ijms242015200
67.
IkedaYBiroSKamogawaYYoshifukuSEtoHOriharaKet alRepeated thermal therapy upregulates arterial endothelial nitric oxide synthase expression in Syrian golden hamsters. Jpn Circ J. (2001) 65:434–8. 10.1253/jcj.65.434
68.
IkedaYBiroSKamogawaYYoshifukuSEtoHOriharaKet alRepeated sauna therapy increases arterial endothelial nitric oxide synthase expression and nitric oxide production in cardiomyopathic hamsters. Circ J. (2005) 69:722–9. 10.1253/circj.69.722
69.
ShinsatoTMiyataMKubozonoTIkedaYFujitaSKuwahataSet alWaon therapy mobilizes CD34+ cells and improves peripheral arterial disease. J Cardiol. (2010) 56:361–6. 10.1016/j.jjcc.201.08.004
70.
TeiCShinsatoTKiharaTMiyataM. Successful thermal therapy for end-stage peripheral artery disease. J Cardiol. (2006) 47:163–4.
71.
HussainJCohenM. Clinical effects of regular dry sauna bathing: a systematic review. Evid Based Complement Alternat Med. (2018) 2018:1857413. 10.1155/2018/1857413
72.
AnvariEVachharajaniTJ. The hemodialysis access surveillance controversy continues. Kidney Int Rep. (2020) 5:1848–50. 10.1016/j.ekir.2020.09.037
73.
LinCCChangCFLaiMYChenTWLeePCYangWC. Far-infrared therapy: a novel treatment to improve access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients. J Am Soc Nephrol. (2007) 18:985–92. 10.1681/ASN.2006050534
74.
LuurilaOJ. The sauna and the heart. J Intern Med. (1992) 231:319–20. 10.1111/j.1365-2796.1992.tb00938.x
75.
Kukkonen-HarjulaKKauppinenK. Health effects and risks of sauna bathing. Int J Circumpolar Health. (2006) 65:195–205. 10.3402/ijch/v65i3.18102
76.
GarollaATorinoMSartiniBCosciIPatassiniCCarraroUet alSeminal and molecular evidence that sauna exposure affects human spermatogenesis. Hum Reprod. (2013) 28:877–85. 10.1093/humrep/det020
77.
RavanelliNCasasolaWEnglishTEdwardsKMJayO. Heat stress and fetal risk. Environmental limits for exercise and passive heat stress during pregnancy: a systematic review with best evidence synthesis. Br J Sports Med. (2019) 53:799–805. 10.1136/bjsports-2017-097914
78.
RapolaJSaxénLGranrothG. Anencephaly and the sauna. Lancet. (1978) 311(8074):1162. 10.1016/S0140-6736(78)90348-3
Summary
Keywords
peripheral arterial disease, cardiovascular disease, heat therapy, sauna bathing, cardiovascular health, exercise therapy
Citation
Sastriques-Dunlop S, Elizondo-Benedetto S and Zayed MA (2025) Sauna use as a novel management approach for cardiovascular health and peripheral arterial disease. Front. Cardiovasc. Med. 12:1537194. doi: 10.3389/fcvm.2025.1537194
Received
15 December 2024
Accepted
21 February 2025
Published
11 March 2025
Volume
12 - 2025
Edited by
Nicola Mumoli, ASST Ovest Milanese, Italy
Reviewed by
Ilkka Ha Heinonen, University of Turku, Finland
Daniel Craighead, University of Minnesota Twin Cities, United States
Grzegorz K. Jakubiak, Medical University of Silesia, Poland
Updates
Copyright
© 2025 Sastriques-Dunlop, Elizondo-Benedetto and Zayed.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mohamed A. Zayed zayedm@wustl.edu
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.